NO20084595L - Device by fracture element - Google Patents

Device by fracture element

Info

Publication number
NO20084595L
NO20084595L NO20084595A NO20084595A NO20084595L NO 20084595 L NO20084595 L NO 20084595L NO 20084595 A NO20084595 A NO 20084595A NO 20084595 A NO20084595 A NO 20084595A NO 20084595 L NO20084595 L NO 20084595L
Authority
NO
Norway
Prior art keywords
weakness
points
fracture element
fracture
switched
Prior art date
Application number
NO20084595A
Other languages
Norwegian (no)
Inventor
Roy Andre Weum
Einar Totland
Audun Solstad-Nielsen
Daniel Vargas Rodrigo
Torulf Hagner
Original Assignee
Fmc Kongsberg Subsea As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Kongsberg Subsea As filed Critical Fmc Kongsberg Subsea As
Priority to NO20084595A priority Critical patent/NO20084595L/en
Publication of NO20084595L publication Critical patent/NO20084595L/en

Links

Landscapes

  • Working Measures On Existing Buildindgs (AREA)

Abstract

Oppfinnelsen angår et bruddelement (20; 44) som kan utgjøre en del av en strekkramme (10) for bruk ved brønnintervensjon til havs. Det nye ved oppfinnelsen er at bruddelementet kan ha minst to svekningspunkter og at den kan omstilles mellom minst to stillinger som korresponderer med de to svekningspunkter.The invention relates to a fracture element (20; 44) which may form part of a tension frame (10) for use in offshore well intervention. The new feature of the invention is that the breaking element can have at least two points of weakness and that it can be switched between at least two positions corresponding to the two points of weakness.

NO20084595A 2008-10-29 2008-10-29 Device by fracture element NO20084595L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20084595A NO20084595L (en) 2008-10-29 2008-10-29 Device by fracture element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20084595A NO20084595L (en) 2008-10-29 2008-10-29 Device by fracture element

Publications (1)

Publication Number Publication Date
NO20084595L true NO20084595L (en) 2010-04-30

Family

ID=42289269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084595A NO20084595L (en) 2008-10-29 2008-10-29 Device by fracture element

Country Status (1)

Country Link
NO (1) NO20084595L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080396B2 (en) 2010-06-24 2015-07-14 Scan Tech Produkt As Telescopic elevator bail and method of using the elevator bail

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080396B2 (en) 2010-06-24 2015-07-14 Scan Tech Produkt As Telescopic elevator bail and method of using the elevator bail

Similar Documents

Publication Publication Date Title
DK3205334T3 (en) Method and composition for the treatment of ocular hypertension and glaucoma
NO20084923L (en) N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors
DK2796469T3 (en) New compositions and methods for the treatment of IgE-mediated disorders
EA201101523A1 (en) METHODS OF TREATMENT OF METABOLIC DISORDERS, USING EPIMETABOLIC SWITCHES, MULTI-ASPECT INTRACELLULAR MOLECULES OR IMPACT FACTORS
BRPI0607430A2 (en) comfortable ophthalmic device and methods of its production
NO20084850L (en) MGLUR5 modulators I
DK1988777T3 (en) Pyrazoles for the treatment of obesity and other cns disorders
NO20081111L (en) New encapsulated pyrazinoylguanidine sodium channel blockers
BRPI0911471A2 (en) very high frequency vibratory flow meter, and method of operating, and of forming the same
DK2200588T3 (en) COMPOSITIONS CONCERNING LIPOFILE ACTIVE RELATIONS AND METHOD OF PRODUCTION THEREOF
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
EA201000714A1 (en) ALPHA- (N-SULPHONAMIDO) ACETAMIDE COMPOUND AS A PRODUCT INHIBITOR INHIBITOR BET AMYLOID PEPTIDE
ATE486597T1 (en) 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION
EA200870424A1 (en) METHODS OF APPLICATION OF GPR119 RECEPTOR TO IDENTIFY CONNECTIONS THAT CAN BE USED TO INCREASE THE BONE MASS
NO20075268L (en) Process for the preparation of opioid modulators
EA201171063A1 (en) PHARMACEUTICAL COMPOSITIONS OF OLMESARTAN
NO20082174L (en) 3,5-disubstituted phenylpiperidines as modulators of dopamine neurotransmission
CR20140494A (en) DGAT1 INHIBITORS OF ETER CYCLING HEAD BRIDGE
MX2010008397A (en) Inhibitors of the chemokine receptor cxcr3.
DK2310003T3 (en) Inhibitors of Carnitine-Palmitoyl-Transferase-1 for the Treatment and Prevention of Disorders Caused by Delipidation of Neural Tissue
SMAP200800062A (en) Terfenile derivatives for the treatment of morbid alzheimers
DK2010184T3 (en) Implants for the treatment of dopamine associated conditions
BRPI0911059A2 (en) device, installation and process for extracting material at the bottom of a body of water
MY161101A (en) Liquid formulations of rupatadine fumarate
CL2011002618A1 (en) Compounds derived from 2,5-disubstituted arylsulfonamides; pharmaceutical composition comprising them; and use of the compound or composition as ccr3 modulators to prevent or treat an inflammatory disease such as asthma, exercise-induced asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis or chronic obstructive disease.